Dhruv Sareen, PhD is the founding Executive Director and Chief Biomanufacturing Officer of the Cedars-Sinai Biomanufacturing Center (CBC), and a Professor at Cedars-Sinai Medical Center. He built the CBC into a cGMP facility supporting IND-enabling clinical trials and has served as site director across multiple cell and gene therapy programs reaching human patients. His work spans iPSC derivation, directed differentiation, genome engineering, hypoimmune cell line development, and automation-driven process scale-up. A prolific inventor with over 30 patents and 60 peer-reviewed publications, he leads the CBC as a Partnership Development Manufacturing Organization and actively builds ventures and industry collaborations to accelerate the translation of next-generation cell therapies from discovery to patients at scale.